Back to Report Store Home

Frontier Pharma: Versatile Innovation in Oncology - Identifying and Commercializing Versatile First-in-Class Innovation

  • Published: Jul-2015
  • Report Code: GBIHC364MR
  • Report Format: pdf

Description

List of Tables

Table 1: Epidemiology by Top 20 Most Common Cancer Sites, 2012

Table 2: Epidemiology by Top 20 Most Common Cancer Sites, 2012

Table 3: Epidemiology by Top 20 Most Common Cancer Sites, 2012

Table 4: Epidemiology by Top 20 Most Common Cancer Sites, 2012

Table 5: TNM Staging, 2015

Table 6: Karnofsky Scores and Equivalent ECOG Staging, 2015

Table 7: Optimal and Actual Radiation Therapy Usage Rates in US, 1995–2000

Table 8: Optimal and Actual Chemotherapy Usage Rates in Australia, 2010

Table 9: Optimal and Actual Chemotherapy Usage Rates in the US, 2008

Table 10: Frequency of Mutations in Components in PI3K Alpha Catalytic Isoform, by Cancer Type

Table 11: Frequency of Mutations in Components in Akt Proteins, by Cancer Type

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$6995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$13990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$20985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards